Perioperative myocardial ischaemia and myocardial infarction

Česká verzia

Authors: Vaněk Tomáš ¹; Špegár Ján ²
Authors place of work: Kardiochirurgická klinika, 3. LF UK, Praha ¹; Cardiothoracic Anaesthesia, Freeman Hospital, Newcastle upon Tyne, UK ²
Published in the journal: Anest. intenziv. Med., 25, 2014, č. 6, s. 418-426
Category: Anesteziologie - Přehledový článek

Summary

Perioperative myocardial ischaemia and myocardial infarction have become a growing problem bringing an increase in mortality, hospital length of stay and financial costs. The incidence is higher postoperatively than in the immediate preoperative and perioperative period. There are two distinct patho-physiological mechanisms which may lead to perioperative myocardial infarction: myocardial injury related to the rupture, fissuring, erosion or dissection of an atherosclerotic plaque (myocardial infarction type 1) and prolonged imbalance in myocardial oxygen supply and demand (myocardial infarction type 2). The review article discusses the diagnostics (ECG, cardiac biomarkers, intraoperative ECHO), prevention (the question of preoperative myocardial revascularization) and management according to guidelines reflecting Evidence Based Medicine.

Keywords:
myocardial ischaemia – myocardial infarction – perioperative period

Zdroje

1. Weiser, T. G., Regenbogen, S. E., Thompson, K. D. et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet, 2008, 372, p. 139–144.

2. Lee, T. H., Marcantonio, E. R., Mangione, C. M. et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major non-cardiac surgery. Circulation, 1999, 100, p. 1043–1049.

3. Fleisher, L. A., Eagle, K. A., Shaffer, T., Anderson, G. F. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population. Anesth. Analg., 1999, 89, p. 849–855.

4. Grobben, R. B., van Klei, W. A., Grobbee, D. E., Nathoe, H. M.The aetiology of myocardial injury after non-cardiac surgery. Neth. Heart J., 2013, 21, p. 380–388.

5. Mangano, D. T., Browner, W. S., Hollenberg, M., London, M. J., Tubau, J. F., Tateo, I. M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery: the Study of Perioperative Ischemia Research Group. N. Engl. J. Med., 1990, 323, p. 1781–1788.

6. Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., The Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Europ. Heart J., 2012, 33, p. 2551–2567.

7. Vojáček, J., Janský, P., Janota, T. Třetí univerzální definice infarktu myokardu. Cor. Vasa, 2013, 55, p. e228–e235.

8. Landesberg, G., Beattie, W. S., Mosseri, M., Jaffe, A. S., Alpert, J. S. Perioperative myocardial infarction. Circulation, 2009, 119, p. 2936–2944.

9. London, M. J., Hollenberg, M., Wong, M. G. et al. Intraoperative myocardial ischemia: Localization by continuous 12-lead electrocardiography. Anesthesiology, 1988, 69, p. 232–241.

10. Landesberg, G. Monitoring for myocardial ischemia. Best Pract. Res. Clin. Anaesthesiol. 2005, 19, p. 77–95.

11. Landesberg, G., Mosseri, M., Zahger, D. et al. Myocardial infarction following vascular surgery: the role of prolonged, stress-induced, ST-depression-type ischemia. J. Am. Coll. Cardiol., 2001, 37, p. 1839–1845.

12. Li, S. L., Wang, D. X., Wu, X. M., Li, N., Xie, Y. Q. Perioperative acute myocardial infarction increases mortality following noncardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013, 27, p. 1277–1281.

13. Gupta, B. P., Huddleston, J. M., Kirkland, L. L. et al. Clinical presentation and outcome of perioperative myocardial infarction in the very elderly following hip fracture surgery. J. Hosp. Med., 2012, 7, p. 713–716.

14. Singh, A., Antognini, J. F. Perioperative hypotension and myocardial ischemia: Diagnostic and therapeutic approaches. Ann. Card. Anaesth., 2011, 14, p. 127–132.

15. Khan, J., Alonso-Coello, P., Devereaux, P. J. Myocardial injury after noncardiac surgery. Curr. Opin. Cardiol., 2014, 29, p. 307–311.

16. Vision Study Writing Group Myocardial injury after noncardiac surgery. A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day outcomes. Anesthesiology, 2014,120, p. 564–578.

17. Goldman, L., Caldera, D. L., Nussbaum, S. R. et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N. Engl. J. Med., 1977, 297, p. 845–850.

18. Owens, W. D., Felts, J. A., Spitznagel, E. L. ASA physical status classifications: a study of consistency of ratings. Anesthesiology, 1978, 49, p. 239–243.

19. Detsky, A. S., Abrams, H. B., McLaughlin, J. R. et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J. Gen. Intern. Med., 1986,1, p. 211–219.

20. Lee, T. H., Marcantonio, E. R., Mangione, C. M. et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation, 1999, 100, p. 1043–1049.

21. Gupta, P. K., Gupta, H., Sundaram, A. et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation, 2011, 124, p. 381–387.

22. McFalls, E. O., Ward, H. B., Moritz, T. E. et al. Coronary-artery revascularization before elective major vascular surgery. N. Engl. J. Med., 2004, 351, p. 2795–2804.

23. Poldermans, D., Schouten, O., Vidakovic, R. et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J. Am. Coll. Cardiol., 2007, 49, p. 1763–1769.

24. Wijns, W., Kohl, P., Danchin, N. et al. Guidelines on myocardial revascularization. Eur. Heart J., 2010, 31, p. 2501–2555.

25. Montalescot, G., Sechtem, U., Achenbach, S. et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur. Heart J., 2013, 34, p. 2949–3003.

26. Hassan, S. A., Hlatky, M. A., Boothroyd, D. B. et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am. J. Med., 2001, 110, p. 260–266.

27. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N. Engl. J. Med., 1996, 335, p. 217–225. [Erratum: N. Engl. J. Med., 1997, 336, p. 147.]

28. Hlatky, M. A., Boothroyd, D. B., Bravata, D. M. et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet, 2009, 373, p. 1190–1197.

29. Brilakis, E. S., Orford, J. L., Fasseas, P. et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am. J. Cardiol., 2005, 96, p. 512– 514.

30. Wilson, S. H., Rihal, C. S., Bell, M. R., Velianou, J. L., Hol-mes, D. R. Jr., Berger, P. B. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am. J. Cardiol., 1999, 83, p. 1006–1011.

31. Widimský, P., Moťovská, Z., Vaněk, T., Línková, H., Kočka, V. Protocols of antithrombotic therapy in a University Cardiocenter. Cor. Vasa, 2013, 55, p. e201–e206.

32. Mookadam, F., Carpenter, S. D., Thota, V. R. et al. Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery. Future Cardiol., 2011, 7, p. 69–75.

33. Glance, L. G., Lustik, S. J., Hannan, E. L. et al. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann. Surg., 2012, 255, p. 696–702.

34. Cohen, M. C., Aretz, T. H. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc. Pathol., 1999, 8, p. 133–139.

35. Kristensen, S. D., Knuuti, J., Saraste, A. et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment of the European Society of Cardiology (ESC) and European Society of Cardiology (ESA). Eur. Heart J., 2014 [Epub ahead of print] doi:10.1093/eurheartj/ehu282.

36. Fleisher, L. A., Fleischmann, K. E., Auerbach, A. D. et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. J. Am. Coll. Cardiol., 2014, [Epub ahead of print] doi:10.1016/j.jacc.2014.07.944.

37. O’Gara, P. T., Kushner, F. G., Ascheim, D. D. et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J. Am. Coll. Cardiol., 2013, 61, p. e78–e140.

38. Task Force on the management of ST-segment elevationacute myocardial infarction of the European Society of Car-diology (ESC) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J., 2012, 33, p. 2569–2619.

39. Hamm, C. W., Bassand, J. P., Agewall, S. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J., 2011, 32, p. 2999–3054.

40. van Veen, J. J., Maclean, R. M., Hampton, K. K. et al. Protamine reversal of low molecular weight heparin: clinically effective? Blood Coagul. Fibrinolysis, 2011, 22, p. 565–570.